Skip to main content

Table 4 Combination of ADAMTS13 and von Willebrand factor and mortality

From: Von Willebrand factor, ADAMTS13 and mortality in dialysis patients

 

Total

N=956

Mortality rate per

1000 patient years

Crude

HR (95% CI)

Adjusteda

HR (95% CI)

All-cause mortality

 VWF p<75 AND ADAMTS13 p>25

549

125

reference

reference

 VWF p<75 AND ADAMTS13 p≤25

168

159

1.3

(0.9-1.7)

1.2

(0.9-1.7)

 VWF p≥75 AND ADAMTS13 p>25

168

197

1.6

(1.2-2.1)

1.3

(1.0-1.8)

 VWF p≥75 AND ADAMTS13 p≤25

71

241

2.0

(1.3-2.9)

2.0

(1.3-3.0)

Cardiovascular mortality

 VWF p<75 AND ADAMTS13 p>25

549

65

reference

reference

 VWF p<75 AND ADAMTS13 p≤25

168

79

1.2

(0.8-1.9)

1.2

(0.7-1.8)

 VWF p≥75 AND ADAMTS13 p>25

168

99

1.5

(1.0-2.3)

1.2

(0.8-1.9)

 VWF p≥75 AND ADAMTS13 p≤25

71

112

1.8

(1.0-3.1)

1.8

(1.0-3.2)

Non-cardiovascular mortality

 VWF p<75 AND ADAMTS13 p>25

549

60

reference

reference

 VWF p<75 AND ADAMTS13 p≤25

168

79

1.3

(0.8-2.1)

1.3

(0.8-2.1)

 VWF p≥75 AND ADAMTS13 p>25

168

99

1.7

(1.1-2.5)

1.5

(0.9-2.3)

 VWF p≥75 AND ADAMTS13 p≤25

71

128

2.2

(1.3-3.7)

2.1

(1.2-3.7)

  1. aAdjusted for age, sex, body mass index, cardiovascular disease, smoking, dialysis modality, primary kidney disease, use of antithrombotic medication, systolic blood pressure, albumin, C-reactive protein and residual GFR